Skip to main content
. Author manuscript; available in PMC: 2007 Oct 24.
Published in final edited form as: Biol Psychiatry. 2006 Dec 11;62(2):179–186. doi: 10.1016/j.biopsych.2006.09.025

Table 2.

Demographic characteristics1 of the patient and healthy control groups

Characteristic NC
(n = 316)
SZ
(n = 106)
BD
(n = 66)
Statistic p <
Age (years) 54.5 ±18.6a 40.0 ±11.1b 41.5 ±11.5b F(2,483) = 39.6 0.001
Sex (male:female %) 44:56a 69:31b 38:62a χ(2)2=23.2 0.001
Race (w:b:o %) 81:17:2a 40:55:6b 67:29:5c χ(4)2=64.4 0.001
Education (years) 14.3 ±3.0a 12.0 ±2.4b 14.8 ±3.0a F(2,483) = 27.6 0.001
Est. premorbid IQ 105.2 ±10.1a 96.5 ±10.5b 103.7 ±10.9a F(2,483) = 28.3 0.001
Age at onset (years) 22.9 ±7.5 24.9 ±9.0 t(98.5) = -1.5 0.163
Illness duration (years) 17.1 ±10.5 16.3 ±11.1 t(143) = 0.5 0.647
# Hospitalizations 5.4 ±6.5 4.2 ±4.4 t(143) = 1.2 0.244
SANS (sum) 10.0 ±6.4 2.5 ±2.9 t(83.6) = 7.8 0.001
SAPS (sum) 5.1 ±4.1 1.8 ±2.6 t(90.6) =4.3 0.001
Typical antipsychotic (%) 34 4 χ(1)2=15.0 0.001
Atypical antipsychotic (%) 75 47 χ(1)2=13.1 0.001
Any antidepressant (%) 23 48 χ(1)2=11.3 0.001
Lithium (%) 4 50 χ(1)2=42.3 0.001
Any anticonvulsant (%) 13 42 χ(1)2=18.4 0.001

Note: For three-group analyses, different subscripts denote significant (p < .05) differences. SZ = schizophrenia; BD = bipolar disorder; NC = normal control. Estimated premorbid IQ based on the NART-R (Blair and Spreen 1989).

1

Shown as mean ±standard deviation unless otherwise indicated.

2For race, w = white, b = black, o = “other.”